Le Tourneau C - Search Results

1

A Phase II trial of erlotinib as maintenance treatment after gemcitabine plus platinum-based chemotherapy in patients with recurrent and/or metastatic nasopharyngeal carcinoma.

You B, Le Tourneau C, Chen EX, Wang L, Jarvi A, Bharadwaj RR, Kamel-Reid S, Perez-Ordonez B, Mann V, Siu LL. You B, et al. Among authors: le tourneau c. Am J Clin Oncol. 2012 Jun;35(3):255-60. doi: 10.1097/COC.0b013e31820dbdcc. Am J Clin Oncol. 2012. PMID: 21358293 Clinical Trial.

2

Molecular targeted therapy of head and neck cancer: review and clinical development challenges.

Le Tourneau C, Faivre S, Siu LL. Le Tourneau C, et al. Eur J Cancer. 2007 Nov;43(17):2457-66. doi: 10.1016/j.ejca.2007.08.016. Epub 2007 Sep 27. Eur J Cancer. 2007. PMID: 17904355 Review.

3

Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck.

Le Tourneau C, Siu LL. Le Tourneau C, et al. Curr Opin Oncol. 2008 May;20(3):256-63. doi: 10.1097/CCO.0b013e3282f9b575. Curr Opin Oncol. 2008. PMID: 18391623 Review.

4

Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.

Le Tourneau C, Vidal L, Siu LL. Le Tourneau C, et al. Drug Resist Updat. 2008 Jun;11(3):99-109. doi: 10.1016/j.drup.2008.04.001. Epub 2008 Jun 2. Drug Resist Updat. 2008. PMID: 18515176 Review.

5

Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor.

Le Tourneau C, Siu LL. Le Tourneau C, et al. Expert Opin Investig Drugs. 2008 Aug;17(8):1247-54. doi: 10.1517/13543784.17.8.1247. Expert Opin Investig Drugs. 2008. PMID: 18616420 Review.

6

Molecularly targeted agents in the treatment of recurrent or metastatic squamous cell carcinomas of the head and neck.

Le Tourneau C, Chen EX. Le Tourneau C, et al. Hematol Oncol Clin North Am. 2008 Dec;22(6):1209-20, ix. doi: 10.1016/j.hoc.2008.08.002. Hematol Oncol Clin North Am. 2008. PMID: 19010269 Review.

7

Dose escalation methods in phase I cancer clinical trials.

Le Tourneau C, Lee JJ, Siu LL. Le Tourneau C, et al. J Natl Cancer Inst. 2009 May 20;101(10):708-20. doi: 10.1093/jnci/djp079. Epub 2009 May 12. J Natl Cancer Inst. 2009. PMID: 19436029 Free PMC article. Review.

8

Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinoma.

Le Tourneau C, Faivre S, Ciruelos E, Domínguez MJ, López-Martín JA, Izquierdo MA, Jimeno J, Raymond E. Le Tourneau C, et al. Am J Clin Oncol. 2010 Apr;33(2):132-6. doi: 10.1097/COC.0b013e318199fb6e. Am J Clin Oncol. 2010. PMID: 19687728 Clinical Trial.

9

Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.

Le Tourneau C, Michiels S, Gan HK, Siu LL. Le Tourneau C, et al. J Clin Oncol. 2009 Dec 10;27(35):5965-71. doi: 10.1200/JCO.2009.22.3685. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805677 Review.

10

Choice of starting dose for molecularly targeted agents evaluated in first-in-human phase I cancer clinical trials.

Le Tourneau C, Stathis A, Vidal L, Moore MJ, Siu LL. Le Tourneau C, et al. J Clin Oncol. 2010 Mar 10;28(8):1401-7. doi: 10.1200/JCO.2009.25.9606. Epub 2010 Feb 1. J Clin Oncol. 2010. PMID: 20124167 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters